FDA Warns About Website Content
The FDA has issued a warning letter to EuroPharma earlier in May concerning links on their website to articles with disease claims. In this letter the FDA asserts that supplement companies that link to articles or published literature from their website product pages are then considering their products to be drugs. EuroPharma disputes these alleged claims stating that the articles were separated by a disclaimer.
Read the full article here: http://www.nutraingredients-usa.com/Regulation/Website-content-an-extension-of-labeling-FDA-warning-letter-shows-companies-need-to-think-about-their-real-estate-space